Thrombosis Canada has launched a national survey of patients currently taking anticoagulants. The survey has been developed by a team of Thrombosis Canada members to identify opportunities to develop resources to help patients who have been diagnosed with thrombosis and prescribed an anticoagulant. This is the first time that Thrombosis Canada has created a survey specifically directed to patients on
Read More2022 Summit of the Thrombosis & Hemostasis Societies of North America Chicago, IL & Online | August 16-18, 2022 Pre-Summit Workshops on August 15 The Thrombosis and Hemostasis Societies of North America (THSNA) will hold its 2022 comprehensive scientific meeting dedicated to thrombosis and hemostasis issues in Chicago, IL from August 16 - 18 including a Pre-Summit Workshop Day on
Read MoreLes professionnels de la santé doivent savoir qu’il existe un risque d’interactions médicamenteuses entre les anticoagulants oraux directs (AOD) et un ingrédient de Paxlovid (le ritonavir) chez les patients traités par un AOD (en particulier l’apixaban et le rivaroxaban) et possiblement admissibles au traitement par Paxlovid, un antiviral contre la COVID-19. Des données probantes indiquent que les patients prenant des
Read More
